A Johns Hopkins-led team of experts in genetics, immunology, epidemiology and allergic disease has embarked on a four-year effort to map the genetic code, or whole genome, of 1,000 people of African descent, including men and women from Baltimore.
Johns Hopkins Medicine International (JHI), the international arm of Johns Hopkins Medicine of Baltimore, Maryland, USA, and the Ministry of Health of Kuwait (MOH) have signed a five-year agreement that calls for JHI to assist Kuwait in improving health care delivery at four of Kuwait’s five secondary care public hospitals and developing in?country talent in [...]
A team of cancer imaging experts at Johns Hopkins has embarked on a five-year research initiative to speed development of early diagnostic tests and new treatments for breast, prostate and other common cancers.
Paul B. Rothman, a distinguished physician, scientist, educator and academic health care leader, was appointed today as the 14th dean of the Johns Hopkins University School of Medicine and second chief executive officer of Johns Hopkins Medicine, a $6.5 billion academic medical center and a health system with a global reach.
Working with guinea pigs, tuberculosis experts at Johns Hopkins and elsewhere have closely mimicked how active but untreated cases of the underlying lung infection lead to permanent eye damage and blindness in people.
G. Daniel Shealer Jr. has been appointed vice president and general counsel of The Johns Hopkins Health System Corporation and The Johns Hopkins Hospital. He succeeds Joanne Pollak, who assumed the duties of chief of staff to the Office of Johns Hopkins Medicine, this past July.
The Armstrong Institute for Patient Safety and Quality of Johns Hopkins Medicine is collaborating with the Lockheed Martin Corporation, a global security and technology company, to create a safer and more efficient hospital intensive care unit (ICU) model. The two organizations will work to streamline complex and fragmented clinical systems and processes to reduce medical [...]
Carrying single DNA letter changes from two different genes together may increase the risk of developing schizophrenia, Johns Hopkins researchers reported in the November 16 issue of Neuron.
People within the Johns Hopkins community have long known that Lillie Shockney is an amazing nurse. Now she’s got the moniker to prove it.
Looking for ways to halt the uncontrolled growth of cancer cells, scientists at Johns Hopkins have found that a new class of drugs, called PARP inhibitors, may block the ability of pre-leukemic cells to repair broken bits of their own DNA, causing these cells to self-destruct. Results of their experiments, expected to be presented at [...]